NEW YORK, March 10, 2015 /PRNewswire/ -- Securities
lawyers at Dunnam & Dunnam are investigating the board of
Pharmacyclics Inc. (NASDAQ: PCYC) in connection with a buyout for
only $261.25 per share. Concerned
PCYC investors are encouraged to contact attorney Hamilton Lindley
by clicking here.
The investigation focuses upon the shareholder value of the
transaction. Under terms of the proposed agreement, Pharmacyclics
shareholders would receive only $261.25 per share in cash and stock. Synergies
may not be fully reflected in the offer price, and there are
indications that management may stay on. The firm's potential
shareholder lawsuit will seek to obtain the highest price
reasonably available and that all important information about the
deal is disclosed.
Dunnam & Dunnam has significant experience representing
shareholders in securities lawsuits nationwide. PCYC stockholders –
or anyone with knowledge about this situation – should contact
lawyer Hamilton Lindley at hlindley@dunnamlaw.com with questions,
toll free at (844) 702-2990 or visit
http://www.dunnamlaw.com/PCYC.
Find these Waco personal injury attorneys, trucking accident
attorneys and car wreck attorneys on Google+, Facebook, Twitter and
LinkedIn.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/pharmacyclics-inc-stockholders-encouraged-to-contact-securities-law-firm-about-takeover-300048206.html
SOURCE Dunnam & Dunnam